Dr. Wendell Kevan Clarkston, MD

Dr. Clarkston practices at Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health.

Dr. Clarkston's NPI, 1144266248, was assigned on June 20, 2006. Dr. Clarkston graduated from University of Missouri, Kansas City, School of Medicine in 1984. Dr. Clarkston holds Missouri license R1732.

Dr. Clarkston's primary practice is Saint Luke's South Hospital, at 12300 Metcalf Avenue, Overland Park, KS 66213 in Johnson County. The practice phone is (913) 317-7000.

Dr. Clarkston's primary practice is Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health. Dr. Clarkston is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Saint Luke's Medical Group. Dmand AI also links Dr. Clarkston to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clarkston practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Clarkston's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Clarkston's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 498 Medicare services from Dr. Clarkston across 10 procedure codes in 2024, for 398 Medicare patients. Medicare paid $49,185 for them.

CMS counts 398 Medicare patients who saw Dr. Clarkston in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clarkston's median patient age at 72, with 62% women.

In 2024, Dr. Clarkston wrote 1,127 Medicare Part D claims for 389 patients. 83% of them were for generic drugs. CMS names the drug for 1,006 of them, across 19 drugs with 11 or more claims each, at $245,514 in total drug cost. In 2023, CMS named 1,131 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Clarkston for performance year 2024, reported as part of a group. Dr. Clarkston accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clarkston as offering telehealth. CMS counts 147 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Clarkston, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Clarkston, published from 2011 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Endoscopy, Digestive System, Gastrointestinal Hemorrhage and Tomography, X-Ray Computed. Dr. Clarkston has published most often in Cancers (Basel). Dr. Clarkston's most frequent co-authors are Fouad Jaber, MD, Saqr Alsakarneh, MD and Hassan Ghoz, MBCHB.

CMS Open Payments shows 7 general payments to Dr. Clarkston from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Pentax of America, Inc. paid the most, $368.

Dr. Clarkston graduated from University of Missouri, Kansas City, School of Medicine in 1984.